Article By:
InvestorsAlley
Friday, May 20, 2022 3:49 AM EDT
Fierce Biotech backs this up: “Biopharmas have $1.7 trillion to spend on deals this year, and big players like Novartis, Pfizer and Merck & Co. have made it pretty clear they’re on the hunt for acquisitions.